Inn: Pembrolizumab/ Pembrolizumab Concentrate Tender - 151781792

Procurement Summary

Country: Ukraine

Summary: Inn: Pembrolizumab/ Pembrolizumab Concentrate for Solution for Infusions, 25 Mg/Ml in 4 Ml According to the Code Dk 021:2015: 33600000-6 — Pharmaceutical Products ( Dk 021:2015: 33652000-5 Antineoplastic Agents And...

Deadline: 04 Nov 2026

Posting Date: 31 Oct 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 151781792

Document Ref. No.: UA-2026-10-29-012819-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 1119680

CPV Classification

33600000 - Pharmaceutical products
33652000 - Antineoplastic and immunomodulating agents

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

INN: Pembrolizumab/ Pembrolizumab concentrate for solution for infusions, 25 mg/ml in 4 ml according to the code DC 021:2015: 33600000-6 — Pharmaceutical products (DC 021:2015: 33652000-5 Antineoplastic agents and immunomodulators)
Type of purchase: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Pembrolizumab: Classification according to ATC: L01FF02, Classification according to INN: Pembrolizumab, Release form: Concentrate for solution for infusions, Dose of the active substance: 25 mg/ml, Volume: 4 milliliters Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date deliveryName
DK 021:2015: 33600000-6 — Pharmaceutical products Pembrolizumab: Classification according to ATC: L01FF02, Classification according to INN: Pembrolizumab, Release form: Concentrate for solution for infusions, Dose of active substance: 25 mg/ml, Volume: 4 milliliters Name Classifier and its corresponding codeQuantity/Measurement unitsPlace of deliveryDate of deliveryName

Documents

 Tender Notice